Artificial intelligence, computational simulations, and extended reality in cardiovascular interventions

S Samant, JJ Bakhos, W Wu, S Zhao… - Cardiovascular …, 2023 - jacc.org
Artificial intelligence, computational simulations, and extended reality, among other 21st
century computational technologies, are changing the health care system. To collectively …

[HTML][HTML] A review on the use of finite element simulations for structural analyses of coronary stenting: What can we do nowadays and what do we need to move forward …

L Antonini, G Poletti, G Pennati, L Petrini - European Journal of Mechanics …, 2023 - Elsevier
In silico studies to perform structural analyses of coronary stenting have attracted the
attention of many researchers in the last 25 years. As a consequence, the finite element …

Computational fluid dynamics as supporting technology for coronary artery disease diagnosis and treatment: an international survey

C Chiastra, M Zuin, G Rigatelli, F D'Ascenzo… - Frontiers in …, 2023 - frontiersin.org
Background Computational fluid dynamics (CFD) is emerging as an effective technology
able to improve procedural outcomes and enhance clinical decision-making in patients with …

The everolimus eluting Synergy MegatronTM drug‐eluting stent platform: Early outcomes from the European Synergy MegatronTM Implanters' Registry

K De Silva, ME Li Kam Wa, T Wells… - Catheterization and …, 2023 - Wiley Online Library
Abstract Background The Synergy MegatronTM is an everolimus‐drug eluting stent that may
offer advantages in the treatment of aorto‐ostial disease and large proximal vessels. Aims …

Advancements and opportunities in characterizing patient-specific wall shear stress imposed by coronary artery stenting

JF LaDisa Jr, A Ghorbannia, DS Marks, P Mason… - Fluids, 2022 - mdpi.com
The success of drug-eluting stents (DES) is limited by restenosis and, to a lesser extent, late
stent thrombosis. Mechanical stimuli have been implicated in these outcomes, with indices …

Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™

P Frederiks, G Castaldi, K McCutcheon… - Expert Review of …, 2024 - Taylor & Francis
Introduction The introduction of drug-eluting coronary stents (DES) into clinical practice in
2002 represented a major milestone in the treatment of obstructive coronary artery disease …